Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy.
Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy.
复制标题
脂肪因子相关基因的多态性可预测接受基于贝伐单抗的化疗的转移性结直肠癌 (mCRC) 患者 (pts) 的治疗结果。
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Volker Heinemann,
中科院分区：
文献类型：
--
作者：
Yuji Miyamoto;Sebastian Stintzing;Wu Zhang;Shu Cao;Yan Ning;Satoshi Okazaki;Martin D. Berger;Mitsukuni Suenaga;Marta Schirripa;Shivani Soni;Satoshi Matsusaka;Dongyun Yang;Roel Gopez;Diana L. Hanna;Afsaneh Barzi;Hideo Baba;Volker Heinemann,
